CRVS · Categories · Form 4

CRVS - SEC Form 4 insider transactions

Corvus Pharmaceuticals Inc. (CRVS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CRVS

• 4d
  SEC Form 4 filed by Director Chan Andrew C.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 91d
  Director Thompson Peter A. exercised 210,000 shares at a strike of $5.33 (SEC Form 4)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 144d
  SEC Form 4 filed by Officer Jones William Benton

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 144d
  SEC Form 4 filed by President and CEO Miller Richard A Md

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 144d
  SEC Form 4 filed by Chief Business Officer Arcara Jeffrey

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 144d
  SEC Form 4 filed by Chief Financial Officer Lea Leiv

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 207d
  SEC Form 4 filed by Director Moore David Scott

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 304d
  Director Orbimed Advisors Llc exercised 1,397,684 in-the-money shares at a strike of $3.50 and sold $4,891,894 worth of shares (1,176,332 units at $4.16) (SEC Form 4)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 304d
  Director Thompson Peter A. exercised 1,397,684 in-the-money shares at a strike of $3.50 and sold $4,891,894 worth of shares (1,176,332 units at $4.16) (SEC Form 4)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 319d
  SEC Form 4 filed by Director Grais Linda

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 319d
  SEC Form 4 filed by Director Clark Ian T

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 319d
  SEC Form 4 filed by Director Morrison Scott W

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 319d
  SEC Form 4 filed by Director Thompson Peter A.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 329d
  Officer Jones William Benton exercised 19,357 shares at a strike of $3.50, increasing direct ownership by 13% to 173,130 units (SEC Form 4)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 357d
  President and CEO Miller Richard A Md exercised 559,073 shares at a strike of $3.50, increasing direct ownership by 97% to 1,136,707 units (SEC Form 4)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 387d
  SEC Form 4 filed by Director Van Den Broek Richard

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 494d
  SEC Form 4 filed by Chief Business Officer Arcara Jeffrey

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 494d
  SEC Form 4 filed by Officer Jones William Benton

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 494d
  SEC Form 4 filed by Chief Financial Officer Lea Leiv

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 494d
  SEC Form 4 filed by President and CEO Miller Richard A Md

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 683d
  SEC Form 4 filed by Director Grais Linda

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 683d
  SEC Form 4 filed by Director Clark Ian T

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 683d
  SEC Form 4 filed by Director Morrison Scott W

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 683d
  SEC Form 4 filed by Director Gould Terry P

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 683d
  SEC Form 4 filed by Director Thompson Peter A.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 717d
  Miller Richard A Md gifted 302,016 shares (SEC Form 4)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 723d
  SEC Form 4 filed by Thompson Peter A.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 723d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 791d
  SEC Form 4 filed by Arcara Jeffrey

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Miller Richard A Md

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Lea Leiv

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Jones William Benton

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Mitchell Edith P.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Grais Linda

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Clark Ian T

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Morrison Scott W

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Gould Terry P

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 875d
  SEC Form 4 filed by Thompson Peter A.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1046d
  SEC Form 4 filed by Thompson Peter A.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1046d
  SEC Form 4 filed by Gould Terry P

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1046d
  SEC Form 4 filed by Clark Ian T

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1046d
  SEC Form 4 filed by Morrison Scott W

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1046d
  SEC Form 4 filed by Grais Linda

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1046d
  SEC Form 4 filed by Mitchell Edith P.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1081d
  SEC Form 4 filed by Grais Linda

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1124d
  SEC Form 4 filed by Miller Richard A Md

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1228d
  SEC Form 4: Jones William Benton bought $15,800 worth of shares (20,000 units at $0.79), increasing direct ownership by 18% to 133,773 units

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1233d
  SEC Form 4: Lea Leiv bought $25,639 worth of shares (34,000 units at $0.75)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1233d
  SEC Form 4: Miller Richard A Md bought $44,827 worth of shares (60,000 units at $0.75)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1311d
  SEC Form 4: Miller Richard A Md bought $19,070 worth of shares (25,000 units at $0.76)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1319d
  SEC Form 4: Miller Richard A Md bought $16,253 worth of shares (20,000 units at $0.81)

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Lea Leiv

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Thompson Peter A.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Mitchell Edith P.

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Jones William Benton

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Miller Richard A Md

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Morrison Scott W

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Grais Linda

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Clark Ian T

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)
• 1355d
  SEC Form 4 filed by Gould Terry P

  4 - Corvus Pharmaceuticals, Inc. (0001626971) (Issuer)

Other CRVS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends